Japan is grappling with significant drug shortages amid a severe flu outbreak that has seen cases surge to record highs. Since flu cases in Japan hit unprecedented numbers in late December last year, hospitals and pharmacies across the country have been facing shortages of essential flu medication.
According to China Media Group, the shortage has been attributed to uneven stock distribution, a situation exacerbated by excessive hoarding by certain medical institutions. As demand for antiviral drugs soared, the panic buying phenomenon has strained the supply chain, leaving many patients without access to necessary treatment.
Japan's National Institute of Infectious Diseases reported that from September 2, 2024, to January 26, 2025, the country recorded approximately 9.523 million flu cases. This staggering figure, released on January 31, underscores the severity of the outbreak and the immense pressure on the healthcare system.
Medical authorities are concerned about the impact of medication shortages on public health. The uneven distribution of flu drugs is affecting not only patients but also the ability of healthcare providers to manage the outbreak effectively.
Efforts are underway to address the shortages and ensure equitable distribution of medication. In the meantime, the public is advised to follow preventive measures to reduce the spread of the flu virus.
Reference(s):
Panic buying causes drug shortages in Japan amid flu outbreak
cgtn.com